REMAP-CAP Study: Rationale and Design

Here is the link that Berry Consultants and the international REMAP-CAP team describe the Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) study in a manuscript published in the Annals of the American Thoracic Society (AnnalsATS).

More Recent News

FACTS 7.1 Release

Berry Consultants is delighted to announce the release of FACTS 7.1 (Fixed and Adaptive Clinical Trial Simulator).